The bone graft uses proprietary nanocrystalline hydroxyapatite and collagen-based biopolymer to promote bone growth in the posterolateral spine. The implantation occurred in Europe and opened the doors for global distribution.
More Articles on Spine Devices:
AxioMed Spine Receives CE Mark for cervical Disc
TransCorp Spine Names Christopher Welch President & CEO
6 New Spine Device Company Financial Reports
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
